Stereotaxis Inc (STXS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Stereotaxis Inc (STXS) has a cash flow conversion efficiency ratio of -0.364x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.20 Million) by net assets ($11.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See STXS net asset quality index to measure how much of total assets are equity-financed.
Stereotaxis Inc - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Stereotaxis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Stereotaxis Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Stereotaxis Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Stereotaxis Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LGI Ltd
AU:LGI
|
0.105x |
|
LWSABAH
KLSE:5328
|
N/A |
|
SICHUAN ENG.INV.DEV.H YC1
F:84H
|
N/A |
|
Digital Asset Acquisition Corp.
NASDAQ:DAAQ
|
-0.003x |
|
IKIO Lighting Limited
NSE:IKIO
|
0.008x |
|
HLB Pharmaceutical Co. Ltd
KQ:047920
|
0.015x |
|
Dynamix Corporation
NASDAQ:ETHM
|
-0.001x |
|
Marblegate Acquisition Corp
NASDAQ:GATE
|
0.017x |
Annual Cash Flow Conversion Efficiency for Stereotaxis Inc (2002–2024)
The table below shows the annual cash flow conversion efficiency of Stereotaxis Inc from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Stereotaxis Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $11.43 Million | $-8.50 Million | -0.743x | -78.27% |
| 2023-12-31 | $21.92 Million | $-9.14 Million | -0.417x | -58.19% |
| 2022-12-31 | $31.93 Million | $-8.41 Million | -0.264x | -252.70% |
| 2021-12-31 | $39.42 Million | $-2.95 Million | -0.075x | +14.40% |
| 2020-12-31 | $40.23 Million | $-3.51 Million | -0.087x | +46.06% |
| 2019-12-31 | $28.52 Million | $-4.62 Million | -0.162x | +53.78% |
| 2018-12-31 | $7.27 Million | $-2.55 Million | -0.350x | -254.38% |
| 2017-12-31 | $-20.61 Million | $-4.67 Million | 0.227x | -46.32% |
| 2016-12-31 | $-15.53 Million | $-6.56 Million | 0.423x | +194.59% |
| 2015-12-31 | $-17.63 Million | $-2.53 Million | 0.143x | -80.20% |
| 2014-12-31 | $-12.55 Million | $-9.09 Million | 0.724x | +33.90% |
| 2013-12-31 | $-11.70 Million | $-6.33 Million | 0.541x | -16.10% |
| 2012-12-31 | $-18.79 Million | $-12.12 Million | 0.645x | -61.54% |
| 2011-12-31 | $-18.83 Million | $-31.57 Million | 1.677x | +192.88% |
| 2010-12-31 | $10.48 Million | $-18.91 Million | -1.805x | +38.17% |
| 2009-12-31 | $7.64 Million | $-22.31 Million | -2.919x | +51.39% |
| 2008-12-31 | $4.77 Million | $-28.65 Million | -6.006x | -306.91% |
| 2007-12-31 | $24.19 Million | $-35.71 Million | -1.476x | -69.60% |
| 2006-12-31 | $44.79 Million | $-38.98 Million | -0.870x | +61.51% |
| 2005-12-31 | $18.13 Million | $-40.99 Million | -2.261x | -315.04% |
| 2004-12-31 | $58.39 Million | $-31.81 Million | -0.545x | +43.74% |
| 2003-12-31 | $25.27 Million | $-24.47 Million | -0.968x | -5.54% |
| 2002-12-31 | $24.01 Million | $-22.03 Million | -0.918x | -- |
About Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires thro… Read more